{
    "case_number": "CAC-UDRP-108688",
    "time_of_filling": "2026-05-29 09:38:00",
    "domain_names": [
        "novartis-ltd.com",
        "novchina.com"
    ],
    "case_administrator": "  Iveta Špiclová   (Czech Arbitration Court) (Case admin)",
    "complainant": [
        "Novartis AG "
    ],
    "complainant_representative": "Abion GmbH",
    "respondent": [
        "weisi Xu"
    ],
    "respondent_representative": null,
    "factual_background": "<p>The Complainant is based in Switzerland. It is one of the biggest global pharmaceutical and healthcare groups. In 2025 it achieved net sales of USD 54.5 billion.<\/p>\n<p>The Complainant owns trademark registrations for NOVARTIS in numerous jurisdictions around the world, including in China where the Respondent is based. It conducts its business under the trademark NOVARTIS and operates its official website at <a href=\"http:\/\/www.novartis.com\">www.novartis.com<\/a>. It owns numerous domain names composed of either its trademark NOVARTIS alone, including &lt;novartis.com&gt;, created on 2 April 1996, or in combination with other terms, such as &lt;novartispharma.com&gt;, created on 27 October 1999.<\/p>\n<p>The Respondent is based in China. The Respondent used a privacy service to register the disputed domain name &lt;novartis-ltd.com&gt; on 24 April 2026 and the disputed domain name &lt;novchina.com&gt; on 19 May 2026. The language of the registration agreements is English.&nbsp;<\/p>\n<p>Initially, the disputed domain name &lt;novartis-ltd.com<strong>&gt;<\/strong> resolved to a website that inferred a direct association with the Complainant. The website stated: &ldquo;Novartis Health Limited is a Hong Kong-based pharmaceutical and healthcare solutions company&rdquo;. It offered &ldquo;Integrated Pharmaceutical Solutions for Global Markets&rdquo; and &ldquo;Scalable Healthcare Partnerships&rdquo; and asserted: &ldquo;We support healthcare providers, distributors, and pharma partners across Asia, the Middle East, Africa, and Europe&rdquo;. Linked webpages featuring the NOVARTIS trademark purported to offer &ldquo;Pharmaceutical Products&rdquo;, &ldquo;Medical Devices&rdquo; and &ldquo;Biopharmaceutical R&amp;D&rdquo;. The &ldquo;Our Services&rdquo; tab stated: &ldquo;We manufacture and distribute pharmaceutical products in compliance with international standards.&rdquo;<\/p>\n<p>On 29 April 2026, the Complainant sent a takedown request to the Registrar for the disputed domain name &lt;novartis-ltd.com&gt;. On 5 May 2026, the Hostinger Abuse &amp; Fraud Prevention Team notified the Complainant that that website service for the disputed domain name was suspended. Since then, the disputed domain name has not been active.<\/p>\n<p>The disputed domain name &lt;novchina.com&gt; initially resolved to an active website that was similar to the website for the disputed domain name &lt;novartis-ltd.com&gt;. On 10 June 2026, after a takedown request to the Registrar, the website service for the disputed domain name &lt;novchina.com&gt; was also suspended. Since then, it has not been active.<\/p>",
    "other_legal_proceedings": "<p>The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain names.<\/p>",
    "no_response_filed": "<p>The Complainant contends that the requirements of the Policy have been met and that the disputed domain names should be transferred to it. <br \/>No administratively compliant Response has been filed.<\/p>",
    "rights": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain names are identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
    "no_rights_or_legitimate_interests": "<p>The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain names (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
    "bad_faith": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain names have been registered and are being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
    "procedural_factors": "<p>The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
    "decision": "Accepted",
    "panelists": [
        "Veronica  Bailey"
    ],
    "date_of_panel_decision": "2026-07-15 00:00:00",
    "informal_english_translation": "<p>The Complainant owns the following trademark registrations for NOVARTIS:<\/p>\n<ul>\n<li>International trademark registration number 1349878, registered on 29 November 2016 in classes 9, 10, 41, 42 and 44;<\/li>\n<li>International trademark registration number 1544148, registered on 29 June 2020 in classes 9, 35, 38 and 42;<\/li>\n<li>International trademark registration number 663765, registered on 1 July 1996 in classes 01, 02, 03, 04, 05, 07, 08, 09, 10, 14, 16, 17, 20, 22, 28, 29, 30, 31, 32, 40, and 42; and<\/li>\n<li>European Union trademark registration number 013393641, registered on17 March 2015 in classes 9 and 10.<\/li>\n<\/ul>",
    "decision_domains": {
        "novartis-ltd.com": "TRANSFERRED",
        "novchina.com": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}